​

Amphastar Pharmaceuticals (AMPH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Amphastar Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$712.81M

Latest Revenue (Q)

$188.82M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Amphastar Pharmaceuticals Revenue by Period

Amphastar Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$712.81M10.62%
2023-12-31$644.39M29.14%
2022-12-31$498.99M13.98%
2021-12-31$437.77M25.13%
2020-12-31$349.85M8.53%
2019-12-31$322.36M9.40%
2018-12-31$294.67M22.69%
2017-12-31$240.18M-5.87%
2016-12-31$255.16M1.45%
2015-12-31$251.52M19.51%
2014-12-31$210.46M-8.37%
2013-12-31$229.68M12.41%
2012-12-31$204.32M72.63%
2011-12-31$118.36M-

Amphastar Pharmaceuticals generated $712.81M in revenue during NA 2024, up 10.62% compared to the previous quarter, and up 221.13% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$188.82M3.52%
2024-06-30$182.39M6.14%
2024-03-31$171.84M-3.52%
2023-12-31$178.10M-1.36%
2023-09-30$180.56M23.91%
2023-06-30$145.71M4.06%
2023-03-31$140.02M3.70%
2022-12-31$135.02M12.40%
2022-09-30$120.13M-2.70%
2022-06-30$123.47M2.57%
2022-03-31$120.37M-0.43%
2021-12-31$120.89M7.74%
2021-09-30$112.20M10.36%
2021-06-30$101.66M-1.32%
2021-03-31$103.02M7.40%
2020-12-31$95.92M14.97%
2020-09-30$83.43M-2.77%
2020-06-30$85.81M1.32%
2020-03-31$84.69M1.57%
2019-12-31$83.38M4.05%
2019-09-30$80.14M1.38%
2019-06-30$79.05M-0.93%
2019-03-31$79.79M-11.04%
2018-12-31$89.69M18.73%
2018-09-30$75.54M6.34%
2018-06-30$71.04M21.66%
2018-03-31$58.39M-3.33%
2017-12-31$60.40M4.29%
2017-09-30$57.92M-11.15%
2017-06-30$65.19M15.03%
2017-03-31$56.67M-10.82%
2016-12-31$63.54M-1.06%
2016-09-30$64.22M-5.60%
2016-06-30$68.03M14.60%
2016-03-31$59.37M-22.81%
2015-12-31$76.91M20.42%
2015-09-30$63.87M18.60%
2015-06-30$53.85M-5.33%
2015-03-31$56.89M1.81%
2014-12-31$55.88M-6.42%
2014-09-30$59.71M21.85%
2014-06-30$49.00M6.83%
2014-03-31$45.87M-16.41%
2013-12-31$54.88M-7.49%
2013-09-30$59.32M-5.13%
2013-06-30$62.52M18.05%
2013-03-31$52.96M-

Amphastar Pharmaceuticals generated $188.82M in revenue during Q3 2024, up 3.52% compared to the previous quarter, and up 129.58% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue Breakdown

Amphastar Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 20Dec 19Dec 18
Other$19.15M---
Product$712.81M---
Active Pharmaceutical Ingredient Segment-$18.48M$20.36M$23.61M

Amphastar Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (97.38%), and Other (2.62%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18Mar 18
Product$524.00M$188.82M--------------
Product and Service, Other-$2.40M--------------
Active Pharmaceutical Ingredient Segment--$6.94M$5.14M$8.12M$2.10M$4.87M$3.39M$5.39M$4.41M$5.31M$5.25M$3.78M$7.80M$5.28M-
Finished Pharmaceutical Products Segment------------$82.93M---

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Amphastar Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 20Dec 19Dec 18
UNITED STATES$707.68M---
FRANCE$19.95M---
CHINA$4.34M---
Active Pharmaceutical Ingredient Segment-$18.48M--
U-$333.09M$304.90M$279.12M
C-$3.16M$1.48M-

Amphastar Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (96.68%), FRANCE (2.73%), and CHINA (0.59%).

Quarterly Revenue by Country

CountryDec 24Sep 24Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Sep 18Jun 18Mar 18
UNITED STATES$521.17M$186.51M-------------
FRANCE$15.43M$4.52M-------------
CHINA$4.16M$178.00K-------------
C--$1.13M$1.12M$679.00K$1.96M$295.00K$228.00K$438.00K$59.00K$984.00K----
U--$95.19M$99.17M$90.72M$79.41M$81.90M$81.06M$77.59M$76.07M$74.78M$76.46M$72.48M$68.56M$53.10M
Active Pharmaceutical Ingredient Segment--$6.94M------------

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (96.38%), FRANCE (2.85%), and CHINA (0.77%).

Amphastar Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
NBIXNeurocrine Biosciences$2.36B$622.10M
ALKSAlkermes$1.56B$378.14M
PBHPrestige Consumer Healthcare$1.13B$290.32M
PAHCPhibro Animal Health$977.89M$309.26M
EVOEvotec SE$781.43M$208.73M
AMPHAmphastar Pharmaceuticals$712.81M$188.82M
PCRXPacira BioSciences$700.97M$168.57M
SUPNSupernus Pharmaceuticals$661.82M$175.69M
COLLCollegium Pharmaceutical$631.45M$159.30M
ANIPANI Pharmaceuticals$614.38M$148.33M
IRWDIronwood Pharmaceuticals$351.41M$91.59M
EOLSEvolus$264.31M$60.16M

AMPH Revenue FAQ

What is Amphastar Pharmaceuticals’s yearly revenue?

Amphastar Pharmaceuticals's yearly revenue for 2024 was $712.81M, representing an increase of 10.62% compared to 2023. The company's yearly revenue for 2023 was $644.4M, representing an increase of 29.14% compared to 2022. AMPH's yearly revenue for 2022 was $498.99M, representing an increase of 13.98% compared to 2021.

What is Amphastar Pharmaceuticals’s quarterly revenue?

Amphastar Pharmaceuticals's quarterly revenue for Q3 2024 was $188.82M, a 3.52% increase from the previous quarter (Q2 2024), and a 4.58% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $182.39M, a 6.14% increase from the previous quarter (Q1 2024), and a 25.17% increase year-over-year (Q2 2023). AMPH's quarterly revenue for Q1 2024 was $171.84M, a -3.52% decrease from the previous quarter (Q4 2023), and a 22.72% increase year-over-year (Q1 2023).

What is Amphastar Pharmaceuticals’s revenue growth rate?

Amphastar Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 42.85%, and for the last 5 years (2020-2024) was 103.75%.

What are Amphastar Pharmaceuticals’s revenue streams?

Amphastar Pharmaceuticals's revenue streams in c 24 are Other, and Product. Other generated $19.15M in revenue, accounting 2.62% of the company's total revenue Product generated $712.81M in revenue, accounting 97.38% of the company's total revenue

What is Amphastar Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Amphastar Pharmaceuticals was Product. This segment made a revenue of $712.81M, representing 97.38% of the company's total revenue.